awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36166394-4DE3D80F-2963-4F32-AD40-0CD60F70E262
Q36166394-4DE3D80F-2963-4F32-AD40-0CD60F70E262
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36166394-4DE3D80F-2963-4F32-AD40-0CD60F70E262
New systemic therapy options for advanced sarcomas.
P2860
Q36166394-4DE3D80F-2963-4F32-AD40-0CD60F70E262
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36166394-4DE3D80F-2963-4F32-AD40-0CD60F70E262
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
235b8f757917c6c4f8acbae0788a2d93cbc36f25
P2860
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.